Precision Optics (POCI) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
17 Feb, 2026Executive summary
Q2 FY2026 revenue reached a record $7.4 million, up 64% year-over-year and 10% sequentially, driven by strong production programs in aerospace and single-use medical devices, despite declines in engineering and micro-optics lab revenues.
Operational improvements and leadership changes have begun to address manufacturing inefficiencies, with positive impacts expected in the second half of the fiscal year.
Net loss widened to $1.8 million for the quarter, with EPS of $(0.23), reflecting margin pressures and higher costs.
Product development bookings and Ross Optical backlog are at multi-year highs, signaling a rebound in these segments.
Fiscal 2026 is described as a transition year, with investments in infrastructure and personnel to support future growth.
Financial highlights
Production revenue was $6.4 million, up from $3.1 million year-over-year; engineering revenue was $1.0 million, down 29% year-over-year.
Gross margin declined to 2.8% from 14.2% sequentially and 23.6% year-over-year, impacted by manufacturing scrap, yield issues, and tariff effects.
Net loss was $1.8 million, compared to $1.0 million a year ago and $1.6 million in the prior quarter.
Adjusted EBITDA was -$1.5 million, versus -$0.6 million year-over-year and -$1.2 million sequentially.
Cash at quarter-end was $0.88 million; bank debt stood at $1.6 million.
Outlook and guidance
Full-year revenue guidance raised to $26–$28 million, up from $25 million previously, representing 36%–47% growth over FY25.
Full-year Adjusted EBITDA guidance revised to -$2.5 million to -$3.0 million, reflecting delayed margin recovery.
Q3 expected to show strong improvement; Q4 forecasted to achieve positive Adjusted EBITDA.
Management anticipates current cash is insufficient to fund operations for at least one year, raising substantial doubt about going concern status.
Long-term growth prospects remain strong, with expectations for substantial growth in coming years.
Latest events from Precision Optics
- Shareholders will vote on director elections, executive pay, and auditor ratification at the 2025 meeting.POCI
Proxy Filing3 Feb 2026 - Votes will be cast on director elections, executive pay, and auditor ratification at the 2026 meeting.POCI
Proxy Filing2 Feb 2026 - Annual meeting to elect directors, approve executive pay, and ratify auditor, with strong governance.POCI
Proxy Filing2 Feb 2026 - Record engineering revenue and new orders support double-digit growth expectations for FY2025.POCI
Q4 202420 Jan 2026 - Strong product pipeline and new production ramp-ups set the stage for record growth in 2025.POCI
Lytham Partners Fall 2024 Investor Conference19 Jan 2026 - Net loss widened on lower revenue and margin, but growth is expected as new programs scale.POCI
Q1 202514 Jan 2026 - Single-use endoscopes and the Unity platform are fueling rapid growth and production expansion.POCI
Lytham Partners 2025 Industrials & Basic Materials Investor Summit26 Dec 2025 - Production revenue surged 42% sequentially, with Unity Imaging Platform launch fueling optimism.POCI
Q2 202524 Dec 2025 - Shelf registration allows up to $75M in securities to fund growth amid ongoing losses and supply risks.POCI
Registration Filing16 Dec 2025